标题
Antiviral Therapeutic Approaches for SARS-CoV-2 Infection: A Systematic Review
作者
关键词
-
出版物
Pharmaceuticals
Volume 14, Issue 8, Pages 736
出版商
MDPI AG
发表日期
2021-07-28
DOI
10.3390/ph14080736
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
- (2021) Hany M. Dabbous et al. ARCHIVES OF VIROLOGY
- Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review
- (2021) Reem Hanna et al. Journal of Inflammation Research
- The Johnson & Johnson Vaccine for COVID-19
- (2021) Edward H. Livingston et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19
- (2021) Hatem Elalfy et al. JOURNAL OF MEDICAL VIROLOGY
- Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
- (2021) Nicola Borbone et al. MOLECULES
- An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
- (2021) Omkar Indari et al. Frontiers in Pharmacology
- Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials
- (2021) Chih-Cheng Lai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- COVID-19 mRNA vaccines
- (2021) Qingrui Huang et al. Journal of Genetics and Genomics
- Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
- (2021) Cathrine Axfors et al. Nature Communications
- Delivery Routes for COVID-19 Vaccines
- (2021) Jang Hyun Park et al. Vaccines
- Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
- (2021) Tejas K. Patel et al. Journal of Infection and Public Health
- A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development
- (2021) Zainalabideen A. Abdulla et al. Pathogens
- A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
- (2021) Lauren Forchette et al. Current Medical Science
- Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020
- (2020) Jantien A Backer et al. Eurosurveillance
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
- (2020) N. Lian et al. CLINICAL MICROBIOLOGY AND INFECTION
- Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
- (2020) Dan Yan et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
- (2020) Subramanian Boopathi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
- (2020) Prakhar Vijayvargiya et al. MAYO CLINIC PROCEEDINGS
- Arbidol/IFN-α2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study
- (2020) Ping Xu et al. MICROBES AND INFECTION
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care
- (2020) Susan A Olender et al. CLINICAL INFECTIOUS DISEASES
- AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
- (2020) Andrey A Ivashchenko et al. CLINICAL INFECTIOUS DISEASES
- Ribavirin therapy for severe COVID-19: a retrospective cohort study
- (2020) Song Tong et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients
- (2020) Guiju Gao et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A study on clinical effect of Arbidol combined with adjuvant therapy on COVID‐19
- (2020) Wenyu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
- (2020) Dong Huang et al. JOURNAL OF MEDICAL VIROLOGY
- Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: a retrospective cohort study
- (2020) Andrea Giacomelli et al. JOURNAL OF MEDICAL VIROLOGY
- No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
- (2020) Yin-Qiu Huang et al. Frontiers in Pharmacology
- Remdesivir Use Compared to Supportive Care in Hospitalized Patients with Severe COVID-19: A Single-Center Experience
- (2020) Markos Kalligeros et al. Open Forum Infectious Diseases
- Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors
- (2020) Eric A. Meyerowitz et al. ANNALS OF INTERNAL MEDICINE
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
- (2020) Hong Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
- (2020) Fabrizio Cantini et al. DRUGS
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis
- (2020) Bryony Simmons et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
- (2020) Hamideh Abbaspour Kasgari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU
- (2020) Zeno Pasquini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19
- (2020) Gholamali Eslami et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
- (2020) Arunmozhimaran Elavarasi et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2020) Peter W Horby et al. LANCET
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
- (2020) Mouhamed Yazan Abou-Ismail et al. THROMBOSIS RESEARCH
- Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID‐19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series
- (2020) Wei Gao et al. Virology Journal
- Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
- (2020) Dhan Bahadur Shrestha et al. Virology Journal
- Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
- (2020) David Grimaldi et al. Annals of Intensive Care
- Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
- (2020) Marzieh Nojomi et al. BMC INFECTIOUS DISEASES
- Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
- (2020) Min Joo Choi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
- (2020) Fatemeh Roozbeh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
- (2020) Zarir F. Udwadia et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective
- (2020) Simone Perazzolo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
- (2013) Bart L Haagmans et al. LANCET INFECTIOUS DISEASES
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
- (2012) S. van Boheemen et al. mBio
- The role of programmed-1 ribosomal frameshifting in coronavirus propagation
- (2008) Ewan et al. Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search